Search Main Menu Main Content
  • Change contrast :
Retour à l'accueil du site de la HAS
logo HAS
icone
  • HAS profile
    • Mission
    • Organisational Structure
    • Ethics, transparency and management of conflicts of interest
  • International relations and projects
  • Publications
  1. Industriels
  2. Médicament
  3. RIFINAH (rifampicine/ isoniazide)
  • icone plus
  • My account

    • Email alert Subscription
    • Newsletter Subscription
    • My search
    Refresh
    Please fill in your email address to retrieve your email alerts subscriptions.
    New subscription
    Please fill in your email address to retrieve your newsletter subscriptions.

    You do not have a saved search

    Mon Compte
  • No element in selection

    Favoris
  • Établissements de santé
  • Contact Abonnez-vous aux actualités
Listen Listen
Add to my selection
  • History
  • Technical informations
Share
Share on
Facebook share - facebook.com - new window
Tweeter share - Partager sur Twitter - twitter.com - new window
LinkedIn share - linkedin.com - new window
Print

RIFINAH (rifampicine/ isoniazide)

Medicine - Posted on Nov 30 2018 - Updated on Jun 12 2019
Active substance (DCI)
  • rifampicine
  • isoniazide
history (5)
  • 11/21/18

    RIFINAH (rifampicine/ isoniazide)

    Modifications du RCP suite à un signalement du PRAC sur le risque de survenue de syndrome d’hypersensibilité médicamenteuse ...
    icône flèche
  • 7/20/16

    RIFINAH (rifampicine/ isoniazide)

    Maintien du remboursement dans les mêmes conditions
    icône flèche
  • 2/2/11

    RIFINAH (rifampicine/ isoniazide)

    RIFINAH (rifampicine/ isoniazide)
    icône flèche
  • 10/18/06

    RIFINAH (rifampicine/ isoniazide)

    RIFINAH (rifampicine/ isoniazide)
    icône flèche
  • 2/21/01

    RIFINAH 300 mg/150 mg, comprimé enrobé (boîte de 30)

    RIFINAH 300 mg/150 mg, comprimé enrobé (boîte de 30)
    icône flèche
Technical information
ATC code
  • J04AM02
Manufacturer
SANOFI-AVENTIS FRANCE
Presentation

RIFINAH 300 mg/150 mg, comprimé enrobé (code CIS : 63898512) plaquette(s) de 30 comprimés - Code CIP : 3400932954094

All our publications
    Bacterial infections Drug therapy Pulmonary and pleural diseases

Follow us :

  • Twitter (nouvelle fenêtre)
  • Facebook (nouvelle fenêtre)
  • Youtube (nouvelle fenêtre)
  • LinkedIn (nouvelle fenêtre)
Haute Autorité de Santé
Advancing quality in the fields of health and social care services
  • Eunetha.eu
  • Pasq.eu
  • All our publications by topic and type
  • Opinions on medicines
  • Opinions on medical devices
  • INAHTA briefs
  • Français
  • English
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
PMXuXJqCMscDm1vm